| ASSET | YEAR | % RETURN |
|---|---|---|
Denali Therapeutics (DNLI) | 2017 | -27.42% |
Denali Therapeutics (DNLI) | 2018 | 29.13% |
Denali Therapeutics (DNLI) | 2019 | -14.52% |
Denali Therapeutics (DNLI) | 2020 | 376.99% |
Denali Therapeutics (DNLI) | 2021 | -47.06% |
Denali Therapeutics (DNLI) | 2022 | -37.56% |
Denali Therapeutics (DNLI) | 2023 | -23.68% |
Denali Therapeutics (DNLI) | 2024 | -3.5% |
Denali Therapeutics (DNLI) | 2025 | -37.1% |
